Literature DB >> 22138113

Utilization characteristics of spinal interventions.

Zach I Abbott1, Kavita V Nair, Richard R Allen, Venu R Akuthota.   

Abstract

BACKGROUND CONTEXT: Several investigators have identified an explosive increase in spinal injection rates in the Veterans Administration and Medicare populations. Furthermore, utilization of spinal injection procedures appears to vary by geographic location, subspecialty, and practice setting. Medicare claims analysis has shown that a small percentage of physicians perform a disproportionately large number of injections. Although Medicare utilization has been well characterized, the utilization patterns for privately insured individuals are not clearly known.
PURPOSE: The primary purpose of this article was to investigate whether relatively few providers are responsible for a disproportionately high percentage of interventional spine procedures in privately insured plans and to quantify any such findings. The secondary purpose was to determine if provider specialty is a relevant variable in any identified patterns of disproportionate utilization. STUDY
DESIGN: A descriptive analysis of utilization patterns using the Medstat MarketScan database was conducted between 2003 and 2007. The database contains deidentified medical, pharmacy, and enrollment claims representing 12 to 14 million individuals. PATIENT SAMPLE: A data set was generated based on the following inclusion criteria: all patients aged between 18 and 99 years receiving at least one spinal interventional procedure between 2003 and 2007: epidural steroid injections, intra-articular facet or medial branch blocks, medial branch radio frequency neurotomy, sacroiliac joint injections, and discography. Our inclusion criteria yielded data on nearly 200,000 patients treated by over 20,000 providers. OUTCOME MEASURES: Not applicable.
METHODS: The number of procedures was tallied for a 12-month period beginning with a patient's first procedure claim. The total number of procedures per patient and the mean number of procedures per patient were calculated for the study sample. Within each specialty, all spinal procedures were summed for each individual provider within each procedure category and as an overall total. The overall mean number of therapeutic procedures per patient for all physicians within a specialty was calculated. Within each specialty, the total number of procedures performed by each physician was analyzed in percentiles to highlight any disparity between high- and low-using providers.
RESULTS: The final therapeutic procedure data set contained 196,332 patients who received 875,627 procedures. The principal nine specialties performing these procedures were anesthesiology (49.2% of the total number of procedures in the final data set), physiatry (12.5%), pain management (12.0%), family practice (10.2%), orthopedics (5.5%), radiology (3.0%), neurology (2.8%), internal medicine (2.8%), and neurosurgery (1.9%). The overall mean number of procedures across all categories performed per patient during the 12-month inclusion period was 4.46±6.44. Neurologists and pain management specialists were the only provider groups in which the mean number of procedures per patient exceeded the overall mean. The highest 10% of providers, which encompasses those providers performing a mean greater than or equal to 5.08 procedures per patient per year, perform 36.6% of the total spinal procedures performed. The highest 20% of providers, which encompasses those providers with a mean greater than or equal to 3.75, account for 57.6% of all spinal procedures. The highest 10% of providers perform nine times more procedures per patient compared with the lowest 10% and 4.5 times more procedures than the median. This same pattern of high utilization by disproportionately few providers was observed across all nine specialties.
CONCLUSIONS: These findings demonstrate that relatively few providers are responsible for a disproportionately high percentage of interventional spine procedures. This pattern of marked overutilization by a minority of providers is the dominant characteristic of utilization within all specialties.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22138113     DOI: 10.1016/j.spinee.2011.10.005

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  17 in total

1.  Effect of Previous Caudal Block to Predict Successful Outcome after Adhesiolysis using a Steerable Catheter in Lumbar Failed Back Surgery Syndrome: A Retrospective Study.

Authors:  Ji Yeong Kim; Do-Hyeong Kim; Dong Woo Han; Young Chan Kim; Ji Young Lee; Young Kyung Park; Hue Jung Park
Journal:  Int J Med Sci       Date:  2022-06-06       Impact factor: 3.642

2.  Comparison of Fusion Rates Based on Graft Material Following Occipitocervical and Atlantoaxial Arthrodesis in Adults and Children.

Authors:  Leslie C Robinson; Richard C E Anderson; Douglas L Brockmeyer; Michelle R Torok; Todd C Hankinson
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-11-01       Impact factor: 2.703

3.  Consensus practice guidelines on interventions for lumbar facet joint pain from a multispecialty, international working group.

Authors:  Steven P Cohen; Arun Bhaskar; Anuj Bhatia; Asokumar Buvanendran; Tim Deer; Shuchita Garg; W Michael Hooten; Robert W Hurley; David J Kennedy; Brian C McLean; Jee Youn Moon; Samer Narouze; Sanjog Pangarkar; David Anthony Provenzano; Richard Rauck; B Todd Sitzman; Matthew Smuck; Jan van Zundert; Kevin Vorenkamp; Mark S Wallace; Zirong Zhao
Journal:  Reg Anesth Pain Med       Date:  2020-04-03       Impact factor: 6.288

4.  Providing Epidemiological Data in Lumbar Spine Imaging Reports Did Not Affect Subsequent Utilization of Spine Procedures: Secondary Outcomes from a Stepped-Wedge Randomized Controlled Trial.

Authors:  Pradeep Suri; Eric N Meier; Laura S Gold; Zachary A Marcum; Sandra K Johnston; Kathryn T James; Brian W Bresnahan; Michael O'Reilly; Judith A Turner; David F Kallmes; Karen J Sherman; Richard A Deyo; Patrick H Luetmer; Andrew L Avins; Brent Griffith; Patrick J Heagerty; Sean D Rundell; Jeffrey G Jarvik; Janna L Friedly
Journal:  Pain Med       Date:  2021-06-04       Impact factor: 3.750

5.  Fluoroscopic caudal epidural injections in managing post lumbar surgery syndrome: two-year results of a randomized, double-blind, active-control trial.

Authors:  Laxmaiah Manchikanti; Vijay Singh; Kimberly A Cash; Vidyasagar Pampati; Sukdeb Datta
Journal:  Int J Med Sci       Date:  2012-09-08       Impact factor: 3.738

6.  Fluoroscopic lumbar interlaminar epidural injections in managing chronic lumbar axial or discogenic pain.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Carla D McManus; Vidyasagar Pampati; Ramsin Benyamin
Journal:  J Pain Res       Date:  2012-08-24       Impact factor: 3.133

7.  Assessment of effectiveness of percutaneous adhesiolysis and caudal epidural injections in managing post lumbar surgery syndrome: 2-year follow-up of a randomized, controlled trial.

Authors:  Laxmaiah Manchikanti; Vijay Singh; Kimberly A Cash; Vidyasagar Pampati
Journal:  J Pain Res       Date:  2012-12-20       Impact factor: 3.133

8.  Management of chronic pain of cervical disc herniation and radiculitis with fluoroscopic cervical interlaminar epidural injections.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Vidyasagar Pampati; Bradley W Wargo; Yogesh Malla
Journal:  Int J Med Sci       Date:  2012-07-23       Impact factor: 3.738

9.  Fluoroscopic caudal epidural injections in managing chronic axial low back pain without disc herniation, radiculitis, or facet joint pain.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Carla D McManus; Vidyasagar Pampati
Journal:  J Pain Res       Date:  2012-10-12       Impact factor: 3.133

10.  Assessment of effectiveness of percutaneous adhesiolysis in managing chronic low back pain secondary to lumbar central spinal canal stenosis.

Authors:  Laxmaiah Manchikanti; Kimberly A Cash; Carla D McManus; Vidyasagar Pampati
Journal:  Int J Med Sci       Date:  2012-12-10       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.